Peer-reviewedCC BY-NC-ND 4.0Scientific Reports27 Oct 2026

Prognostic value of systemic inflammation markers in advanced esophageal squamous cell carcinoma treated with second-line nivolumab: a real-world European study

Nieves Martínez-Lago
Paula González Villarroel
Alberto Carral Maseda
Ana Fernández Montes
Marta Covela Rúa
Marinha Costa Rivas
Margarita Reboredo Lopez
Soledad Cameselle García
Noemí De Dios Álvarez
Rafael Varela Ponte
Antia Cousillas Castiñeiras

Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma
Nobuhito Muramoto, Masayoshi Nagata, Hisashi Hirano +7
PLOS One7 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyPLOS
FOLFOX plus nivolumab combination therapy for cisplatin-unfit patients with untreated advanced esophageal squamous cell carcinoma
Nozomu Ogura, Shun Yamamoto, Ryuichi Morita +9
Esophagus10 Jun 2026Peer-reviewedCC BY 4.0Full text2 citedSurgery & anaesthesiaPMC
Treatment patterns and prognostic factors of radiation-associated esophageal fistula in patients with esophageal squamous cell carcinoma: a retrospective cohort study
Journal of thoracic disease14 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Treatment-dependent and independent prognostic value of inflammation-based nutritional indices in immune checkpoint inhibitor-based therapy for esophageal cancer
Hiroki Matsuda, Tomoki Makino, Shuichiro Hara +12
Esophagus28 Aug 2026Peer-reviewedCC BY 4.0Full textOncologyPMC
Regulatory network remodeling and potential non-canonical associations of the transcription factor SP1 during inflammation-to-cancer transformation in esophageal squamous cell carcinoma
Bin Du, Jie Zhang, Huimin Liu +3
Frontiers in Immunology16 Oct 2026Peer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMCPMC

Cite

BibTeX

@article{martinezlago2026prognostic,
  title = {{Prognostic value of systemic inflammation markers in advanced esophageal squamous cell carcinoma treated with second-line nivolumab: a real-world European study}},
  author = {Nieves Martínez-Lago and Paula González Villarroel and Alberto Carral Maseda and Ana Fernández Montes and Marta Covela Rúa and Marinha Costa Rivas and Margarita Reboredo Lopez and Soledad Cameselle García and Noemí De Dios Álvarez and Rafael Varela Ponte and Antia Cousillas Castiñeiras},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-77604-4},
  url = {https://www.nature.com/articles/s41598-026-77604-4},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Prognostic value of systemic inflammation markers in advanced esophageal squamous cell carcinoma treated with second-line nivolumab: a real-world European study
AU  - Nieves Martínez-Lago
AU  - Paula González Villarroel
AU  - Alberto Carral Maseda
AU  - Ana Fernández Montes
AU  - Marta Covela Rúa
AU  - Marinha Costa Rivas
AU  - Margarita Reboredo Lopez
AU  - Soledad Cameselle García
AU  - Noemí De Dios Álvarez
AU  - Rafael Varela Ponte
AU  - Antia Cousillas Castiñeiras
PY  - 2026
DA  - 2026/10/27
JO  - Scientific Reports
DO  - 10.1038/s41598-026-77604-4
UR  - https://www.nature.com/articles/s41598-026-77604-4
SN  - 2045-2322
ER  -

Related

Cite